Events

Join us for a 2-hour virtual expo designed to help clinical trial professionals discover and compare the best Electronic Data Capture (EDC), electronic Clinical Outcome Assessment (eCOA), & Data Management technologies on the market, without the time, cost, or travel of traditional conferences. Whether you are mid-trial or preparing for your next protocol, this showcase...

Stem cells are a powerful frontier in cell and gene therapy, offering pluripotency, self-renewal, and the ability to produce engineered, standardized therapeutic cell populations. iPSC platforms reduce donor variability and support scalable, consistent manufacturing for regenerative medicine, gene correction, and next-generation cell therapies. However, stem cell products are inherently process-defined: cell identity, function, potency, and...

Watch leading CDMOs showcase their current capabilities, facility locations, and timelines—helping you identify the right partners for your large molecule development and manufacturing needs. Explore the biopharmaceutical landscape, including: - Cell line development, fermentation, and advanced purification - Process optimization and scale-up to meet production demands efficiently - Rigorous quality control practices that support the...

Watch leading CDMOs share their current capabilities, facility locations, and timelines—helping you identify options for your fill/finish development and manufacturing needs. Explore the critical final steps of pharmaceutical manufacturing, including: - Sterile filling and lyophilization (freeze drying) - Advanced packaging technologies - Quality control and regulatory compliance to ensure safe, effective biopharmaceutical delivery What to...

Watch leading CDMOs share their current capabilities, facility locations, and timelines—helping you identify the right partners for your small molecule drug substance development and manufacturing needs. What to expect: - Short digital presentations providing an inside look at supplier capacity - Live Q&A to ask questions and assess whether each CDMO can meet your needs...

Watch leading CDMOs share their current capabilities, facility locations, and timelines—helping you identify the right partners for your analytical services needs. Topics include: - Advanced assay development and method validation - Analytical platforms for large molecules, biomarkers, and emerging therapeutic modalities - Solutions tailored to the unique challenges of modern therapeutics What to expect: -...

In this practical, example driven webinar, Battelle Technical Fellow, Justin Sanchez, together with leading MedTech experts, will break down how AI can be applied to accelerate device development while ensuring safety, reliability, and regulatory alignment. In this free session, you will learn: - How AI delivers value across medical device development - Practical, real-world examples...

Join Deputy Chief Editor of Outsourced Pharma Jeff Buguliskis and our experienced panelists as they break down how to transform your CDMO partnerships from sources of stress into strategic assets. We will share real-world tactics to help you secure your outsourcing strategy, navigate regional regulatory hurdles, and prevent costly delays.

We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. This is a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. Our last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we...

Struggling to improve titre, product quality, or long-term stability in GS-CHO expression systems? In this free webinar, learn how optimized vector design — including advanced promoter engineering — can significantly impact biomanufacturing performance. The session highlights the Lonza GSquad® Pro platform and its high-performance LHP-1 promoter, along with data-driven strategies to improve gene expression control...

Selecting the right route of administration for a complex, large molecule biologic requires careful alignment of formulation, dose, and device strategy. Join Drug Delivery Leader's next live discussion where experts from Merck, GSK, and Drug Hunter Consulting will share key considerations—including formulation complexity, high-dose delivery, patient needs, self-administration, and transitioning between delivery platforms—using examples from...

Particulates and raw material variability remain two of the toughest, most talked about hurdles in cell and gene therapy. In the upcoming Cell & Gene Live, Anthony Blaszczyk, Ph.D., Senior Scientist at the U.S. Pharmacopeia, and Basak Clements, Ph.D., Founder and Senior Advisor at biomatria, join Cell & Gene Chief Editor Erin Harris to examine...

We are very excited to invite you to our indoor BVS Waltham/Winter Street Biotech Community Expo! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. We are inviting all research scientists from the institutes, biotech/pharma and other companies along Winter...

Explore how KBI Biopharma delivers fast, cost-effective, and robust microbial protein process development, tailored for first-in-human (FIH, Phase I) programs and adaptable to each client’s needs for speed, cost, and performance. Learning Objectives: - Key considerations for microbial cell line, fermentation, and purification development for FIH - How milestones align from proof-of-concept to toxicology material...

Regulators are moving the comparability goalpost, shifting the burden of proof from massive clinical trials to deep process understanding. In this new landscape, the ability to define and control CPPs is the only way to ensure a biosimilar remains highly similar to its reference. Join Bioprocess Online’s Jon O’Connell for a virtual Q&A with experts...

As biologics grow more complex and development timelines continue to tighten, many teams could encounter manufacturability challenges related to decisions around media, process, and scalability made earlier in development. Traditional, sequential workflows may not always surface potential challenges until programs are already moving toward scale-up, which can limit flexibility. In this webinar, Thermo Fisher Scientific...

AI is reshaping every industry—and drug discovery is no exception. Across targets, molecules, and data at massive scale, AI is becoming integral to how modern therapeutics are discovered and developed. This panel explores how foundational open‑source AI engines like OpenFold and Boltz are being used across the drug discovery workflow, from target discovery and validation...

In today’s fast-paced biopharma and CDMO environments, single-use assembly design is about confidence in quality, supply continuity, and process performance. This webinar explores how Thermo Scientific™ Single-Use Assemblies are designed to help reduce risk, support flexible manufacturing, and help organizations meet production milestones and maintain momentum when time to market is crucial. Attendees will see...

Phase 2 neurodegenerative trials are increasingly challenged by slow disease trajectories, heterogeneous patient populations, and blunt legacy endpoints that struggle to detect treatment-related change over typical study durations. Traditional scales such as ADAS-Cog and MDS-UPDRS, while well-established, often lack sensitivity in early disease, are vulnerable to rater and practice effects, and may insufficiently capture subtle...